News for Axonics, Inc. (AXNX)

Exploring the Strategic Portfolio Adjustments by the Renowned Investor George Soros (Trades, Portfolio) recently submitted the 13F filing for the fourth quarte

We recently compiled a list of the Jim Cramer Discussed 18 Companies That Hit $100 Billion in Market Cap in 2024. In this article, we are going to take a look at where Boston Scientific Corporation (...

Paragon 28, Inc. (NYSE: FNA), (the ”œCompany”) a leader in foot and ankle surgical solutions, today announced the appointment of Dave Demski to serve as an

BSX's acquisition of Axonics marks its entry into sacral neuromodulation and complements its Urology business.

TEL AVIV, Israel, Nov. 18, 2024 /PRNewswire/ -- SoniVie Ltd., a medical device company developing a proprietary renal denervation system to treat hypertension, announced today the appointment of Raymond W. Cohen to serve as its chairman of the board of directors.

Boston Scientific Corporation (BSX) has announced the completion of its acquisition of Axonics, Inc., a public medical technology company specializing in devi

Axonics (AXNX) stock edged higher by 0.7% after receiving a Nasdaq delisting notice due to its planned sale to Boston Scientific.

Axonics (AXNX) delivered earnings and revenue surprises of 23.08% and 1.46%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Revenue: Achieved $116.2 million, surpassing the analyst estimate of $113.50 million, marking a 25% increase year-over-year.Gross Margin: Improved to 77.2%, up

Earnings call: Boston Scientific reports robust Q3 growth, raises outlook

What investors need to know about the McDonald's E. coli outbreak. Spirit Airlines jumps on report of merger talks with Frontier. Disney reportedly not letting new users sign up via Apple.

Baron Discovery Fund declined in the second quarter of 2024, underperforming its benchmark, the Russell 2000 Growth Index. Click here to read the full fund letter.

Earnings call: Boston Scientific raises full-year outlook after strong Q2

Boston Scientific is also in the process of acquiring Axonics, with the BSX-AXNX merger expected to be completed by H2 2024. Explore more details here.

Baron Small Cap Fund was up 11.81% (Inst.) in Q1 2024, well ahead of the Russell 2000 Growth Index which was up 7.58%. Click here to read the full letter.

NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential...

NEW YORK, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the...

NEW YORK, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential...

Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on the stock and raised its price target from $35 to $41.